Effect of probiotic supplement in treatment of psoriasis
Phase 3
- Conditions
- Psoriasis.Psoriasis vulgarisL40.0
- Registration Number
- IRCT20180712040438N2
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
diagnosed with psoriasis
Subjects aged 15-50 years
Exclusion Criteria
patient with chronic renal failure; hemodialysis
receiving immunosuppressive, anti-inflammatory and corticosteroid drugs
history of supplementation with pre/pro/symbiotic or antioxidants during previous two months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method